How to Start a Pharmaceutical Manufacturing Company in India (2026 Guide)

How to Start a Pharmaceutical Manufacturing Company in India (2026 Guide)

So you want to build a pharmaceutical manufacturing company in India. Maybe you have watched the generics boom from the sidelines, or you are a chemist, formulation expert, or pharma-industry professional who is done working for someone else's brand. Whatever brought you here, you already know one thing: this is not a business you can start on a weekend with a laptop and a logo.

Pharma manufacturing is one of the most rewarding sectors in India — and also one of the most tightly regulated. Get the structure, licences, and compliance right from day one, and you build a business that can supply hospitals, exporters, and global markets for decades. Get it wrong, and you risk product seizures, licence cancellation, or a plant that never opens. This guide walks you through exactly what a founder needs to know before laying the first brick — structure, licences, documents, costs, and the mistakes that quietly kill pharma startups every year.

Why Pharmaceutical Manufacturing in India

India is often called the "pharmacy of the world," and for good reason. The country is among the largest suppliers of generic medicines globally by volume, has a mature ecosystem of API and formulation manufacturers, and enjoys strong government push through Production Linked Incentive (PLI) schemes and bulk drug park initiatives. Domestic demand for formulations, nutraceuticals, and specialty drugs is also expanding rapidly on the back of rising healthcare spending and insurance penetration.

For a founder, this means genuine long-term opportunity — but it also means you are entering a sector where global buyers, hospitals, and regulators expect credible corporate structures, verifiable quality systems, and audit-ready compliance. This is precisely why the right legal foundation matters more here than in almost any other business category. Investors, export partners, and even domestic distributors will ask about your entity structure and licensing status before they ask about your product.

Best Business Structure

For pharmaceutical manufacturing, a Private Limited Company is typically the recommended structure, and for good reason:

• Regulatory credibility — State Drug Control authorities, CDSCO, and pollution control boards generally view a company structure as more stable and accountable than a proprietorship or partnership, which can smoothen licence processing.
• Funding readiness — pharma manufacturing is capital-intensive (plant, machinery, testing labs, working capital). A Private Limited Company can raise equity from investors, venture debt, or bank term loans far more easily than unincorporated structures.
• Limited liability — plant accidents, product liability claims, and environmental compliance failures are real risks in this sector. A Private Limited Company protects promoters' personal assets.
• Perpetual succession and easier ownership transfer — useful if you plan to bring in technical partners, contract manufacturing clients, or eventually exit or list.

An LLP is sometimes used by smaller, single-product contract manufacturers who do not intend to raise external equity, since it offers limited liability with simpler compliance. However, most State Licensing Authorities, export buyers, and PLI scheme guidelines are far more comfortable dealing with companies, so LLP is best treated as a fallback rather than the default choice for anyone serious about scaling.

A One Person Company or proprietorship is generally not advisable here — the licensing, liability, and funding requirements of pharma manufacturing usually outgrow these structures very quickly.

Licences & Registrations You Need

This is the part where most founders underestimate the journey. Pharmaceutical manufacturing sits at the intersection of drug law, environmental law, labour law, and tax law — and every one of these regulators has to sign off before you can legally produce medicines.

• Manufacturing Drug Licence — This is the core, non-negotiable licence for anyone manufacturing drugs in India, issued under the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945. Most manufacturing licences (typically applied for in forms that are commonly referred to as Form 25 / Form 28 and related categories) are issued by the State Drug Control / State Licensing Authority, while certain specified categories of drugs (such as select biologicals, vaccines, and a few other notified categories) fall under the CDSCO (Central Drugs Standard Control Organisation). Exact form numbers and jurisdictional splits are periodically revised, so always confirm the current requirement with the relevant authority or your consultant at the time of filing.
• WHO-GMP / Schedule M compliance — Every drug manufacturing unit is expected to demonstrate Good Manufacturing Practices as prescribed under Schedule M of the Drugs and Cosmetics Rules. This schedule has been undergoing revision to align more closely with WHO-GMP standards, with tightened requirements around quality management systems, documentation, validation, and infrastructure. Compliance timelines and thresholds (including any staggered deadlines based on turnover or unit size) have been subject to change, so treat any specific date you hear as indicative only and verify the current position before finalising your plant design.
• Pollution Control Board Consent — Pharma manufacturing (especially API and bulk drug units) is usually classified as a "Red" or "Orange" category industry depending on the process involved. You will typically need a Consent to Establish (CTE) before construction and a Consent to Operate (CTO) before commercial production, granted by the State Pollution Control Board under the Water (Prevention and Control of Pollution) Act, 1974, the Air (Prevention and Control of Pollution) Act, 1981, and the Environment (Protection) Act, 1986. Effluent treatment, hazardous waste handling, and emission norms are strictly enforced in this sector.
• Factory Licence — Once you set up manufacturing premises with power-driven machinery and workers beyond the specified threshold, a Factory Licence is generally required under the Factories Act, 1948, issued by the State Factories/Labour department. This also covers building safety, worker welfare facilities, and working condition norms.
• GST Registration — mandatory for billing, input tax credit, and interstate supply of pharmaceutical products.
• Trade Licence — from the local municipal corporation or municipality where your unit or registered office is located.
• Fire NOC — a No Objection Certificate from the local fire department is usually required before factory occupancy, and often as a precondition for the Factory Licence and Pollution Control consents.
• Narcotic/Psychotropic Substance Licence — applicable only if your product portfolio includes narcotic drugs or psychotropic substances, regulated separately under the NDPS Act and related rules; most standard formulation manufacturers will not need this.
• EPF/ESIC Registration — becomes mandatory once your workforce crosses the applicable employee-count threshold under the respective labour welfare laws.
• Import Export Code (IEC) — required if you plan to export formulations or APIs, or import raw materials and machinery.
• DPIIT/Startup India Recognition — worth exploring if you qualify, as it can open doors to tax benefits, easier compliance, and access to government schemes relevant to pharma and biotech startups.

Because rules, forms, and thresholds in this sector are amended periodically, treat every specific number or form name above as a working reference, and always confirm the current requirement before you file.

Documents Required

While the exact document list will vary by state and by the category of drug you intend to manufacture, founders should generally be prepared with:

• PAN and Aadhaar of all directors/partners/proprietor
• Certificate of Incorporation, MOA, AOA (for a company) or LLP Agreement
• Site plan and layout plan of the proposed manufacturing premises, usually prepared by a registered architect
• Proof of ownership or lease/rent agreement for the manufacturing site
• List of plant and machinery with specifications and capacity
• Details of technical staff — typically a qualified pharmacist, production in-charge, and quality control/quality assurance personnel with the qualifications prescribed under the Drugs and Cosmetics Rules
• Constitution documents establishing the applicant entity (company/LLP/firm)
• Board resolution authorising the application and the authorised signatory
• Product list / manufacturing formula details for the drugs proposed to be manufactured
• Water testing report and effluent treatment plan for Pollution Control Board consent
• Fire safety compliance documents
• GST registration certificate
• Bank account details and proof of registered office/business address

Your consultant will confirm the state-specific checklist, since State Drug Control departments often have their own additional formats and undertakings.

Step-by-Step Process

1. Choose your structure and incorporate — register a Private Limited Company (recommended) with the Ministry of Corporate Affairs, including PAN, TAN, and a registered office address for the entity.
2. Finalise the product category and site — decide whether you will manufacture formulations, APIs/bulk drugs, or both, since this determines your regulatory pathway, plant design, and pollution category.
3. Prepare the plant layout as per Schedule M/GMP norms — engage an architect and technical consultant familiar with pharma facility design, since layout, air handling, and material flow are scrutinised closely during licensing inspections.
4. Apply for Pollution Control Board Consent to Establish (CTE) — this is generally required before you start construction of the manufacturing unit.
5. Set up plant and machinery, and recruit technical staff — including a qualified production pharmacist and quality control personnel as prescribed.
6. Apply for the Factory Licence with the State Factories/Labour department, and obtain the Fire NOC from the local fire department.
7. Apply for Consent to Operate (CTO) from the State Pollution Control Board once the plant is ready and effluent/waste management systems are functional.
8. Apply for the Manufacturing Drug Licence with the State Drug Control/State Licensing Authority (or CDSCO for specified categories), along with the technical staff details, site plan, and machinery list.
9. Undergo the drug inspector's site inspection — the authority typically inspects the premises, documentation, and quality systems before granting the licence.
10. Obtain GST registration, Trade Licence, and IEC (if exporting) in parallel with the above steps to avoid delays once the drug licence is granted.
11. Set up your Quality Management System — SOPs, batch manufacturing records, stability studies, and validation protocols aligned with Schedule M/GMP expectations, since these will be audited on an ongoing basis, not just at the time of licensing.
12. Register for EPF/ESIC once your headcount crosses the applicable threshold, and evaluate DPIIT/Startup India recognition if you qualify.
13. Commence commercial production only after all licences are in hand, and build a compliance calendar for renewals, periodic inspections, and regulatory updates (such as Schedule M revisions) that may apply to your unit.

Cost & Fees in 2026

Costs for setting up a pharma manufacturing unit vary enormously depending on the state, the scale of the plant, the product category (formulations vs. APIs vs. sterile/injectable units), and whether you are building a greenfield facility or upgrading an existing one. As a rough, indicative guide only — not a quote:

• Incorporation and basic registrations (company formation, PAN/TAN, GST) usually represent a relatively small fraction of overall project cost, often in the range of a few tens of thousands of rupees in professional and government fees, though this can vary based on authorised capital and state-specific stamp duty.
• Government fees for the Manufacturing Drug Licence vary by state and by the number/category of products, and are typically a modest line item compared to the overall project outlay.
• Pollution Control Board consent fees are usually linked to the investment size and pollution category (Red/Orange/Green) of your unit.
• Plant, machinery, and infrastructure costs — this is by far the largest cost component and depends entirely on your product category, batch size, and whether you need cleanroom/sterile manufacturing capability. This can range from a modest investment for a small-scale formulation unit to a very large one for API or sterile injectable manufacturing.
• Professional/consultancy fees for licence documentation, site plan preparation, and liaison with authorities typically add a further cost, usually charged as a fixed package by consultants.

Because these figures are highly sensitive to state, scale, and product category — and because government fee schedules are revised from time to time — treat any number you see online (including here) as directional only. Always get a current, itemised quote before budgeting your project.

Timeline

Timelines for pharma manufacturing setup are typically longer than for most other businesses, given the sequential nature of approvals:

• Incorporation of the company usually takes a short period, commonly a matter of days to a couple of weeks, assuming documents are in order.
• Plant construction and machinery installation, aligned with Schedule M/GMP layout requirements, is usually the longest phase and can take several months depending on the scale of the facility.
• Pollution Control Board consents (CTE and CTO) each typically involve a review and inspection process that can take a few weeks to a few months, depending on the state and category.
• The Factory Licence and Fire NOC processes generally run in parallel with construction completion.
• The Manufacturing Drug Licence application, including the drug inspector's site visit, commonly takes a few weeks to a few months from the time the plant is inspection-ready, though this can extend further if compliance gaps are flagged and need to be rectified.

Overall, founders should realistically plan for the full journey — from incorporation to first commercial batch — to span several months at minimum, and often well over a year for larger or more complex facilities. Because approval timelines depend on state workload, inspection scheduling, and how audit-ready your documentation is, always build buffer time into your business plan rather than anchoring to the fastest-case scenario.

Common Mistakes to Avoid

• Starting construction before finalising the layout against Schedule M/GMP norms — many founders build first and try to retrofit compliance later, which usually means costly rework.
• Underestimating technical staffing requirements — a qualified production pharmacist and quality control personnel are not optional line items; missing or under-qualified staff is one of the most common reasons licence applications get delayed or rejected.
• Choosing the wrong entity structure — proprietorships and informal partnerships often struggle to convince regulators, investors, and export buyers of long-term stability, and cause avoidable friction later when converting to a company.
• Ignoring Pollution Control Board requirements until late — CTE is typically needed before construction, not after; starting civil work without it can lead to compliance notices or forced stoppage.
• Treating GMP as a one-time inspection hurdle rather than an ongoing system — quality management, batch records, and validation protocols need to be maintained continuously, not just prepared for the inspection date.
• Not accounting for state-specific variations — drug licensing, pollution norms, and factory rules can differ meaningfully from state to state; assuming a friend's experience in another state will apply to you is a common and costly error.
• Delaying GST, IEC, and labour registrations — founders often wait until the drug licence comes through before starting these, which then becomes a bottleneck to actually shipping product.
• Not budgeting for compliance updates — since Schedule M and related norms are periodically revised, founders who treat their initial licence as a "set and forget" step often get caught out by tightened requirements later.

FAQs

Q: Can I start pharmaceutical manufacturing as an individual/proprietorship?

Technically it is possible in some cases, but it is generally not advisable. A Private Limited Company is the structure most State Licensing Authorities, investors, and export buyers are comfortable dealing with, and it also gives you limited liability protection, which matters a great deal in a capital-intensive, high-compliance sector like pharma.

Q: Do I need CDSCO approval or is the State Licensing Authority enough?

For most conventional formulation and generic drug manufacturing, the State Drug Control/State Licensing Authority is typically the relevant authority. CDSCO approval generally applies to specific categories such as certain biologicals, vaccines, and a few other notified drug categories. Since the exact categorisation can be updated, it is best to confirm which authority applies to your specific product before applying.

Q: What exactly is Schedule M, and why does it matter so much?

Schedule M under the Drugs and Cosmetics Rules prescribes the Good Manufacturing Practices your facility must follow — covering infrastructure, equipment, documentation, and quality systems. It has been undergoing revision to bring it closer to WHO-GMP standards, with an emphasis on stronger quality management and validation. Because compliance expectations have been tightening, it is worth checking the current version of Schedule M and any applicable compliance timelines before finalising your plant design.

Q: How long does it typically take to get a Manufacturing Drug Licence?

There is no fixed, guaranteed timeline, since it depends on how inspection-ready your facility is, state workload, and whether any compliance gaps are flagged during the drug inspector's visit. Founders should plan for this to be one of the longer approval steps in the overall project timeline rather than assuming a fast turnaround.

Q: Do I need a separate licence for exporting pharmaceutical products?

You will typically need an Import Export Code (IEC) to export, in addition to your manufacturing drug licence. Depending on the destination market, you may also need to meet that country's specific regulatory or GMP certification requirements, which is a separate process from Indian domestic licensing.

Q: What is the difference between Consent to Establish and Consent to Operate?

Consent to Establish (CTE) is typically obtained from the State Pollution Control Board before you start constructing your manufacturing facility, while Consent to Operate (CTO) is obtained once the plant is built and ready to commence production, confirming that your effluent treatment and pollution control systems are functioning as required.

Q: Can an LLP manufacture pharmaceutical products in India?

An LLP can, in principle, hold a manufacturing drug licence, and some smaller contract manufacturers do operate this way. However, most founders planning to scale, raise funding, or work with larger export/institutional buyers find a Private Limited Company structure gives them more credibility and easier access to capital.

Q: Do I need EPF/ESIC registration from day one?

Not necessarily — these registrations typically become mandatory once your employee count crosses the threshold prescribed under the respective laws. However, it is wise to plan for this early, since pharma manufacturing units usually cross these thresholds faster than founders expect once production scales up.

Not sure which licences apply to your specific product category and state? Legal Suvidha's free Start-a-Business Licence & Cost Checker tool can give you a quick, personalised list before you speak to an expert.

Why Founders Choose Legal Suvidha

For 14 years we have taken founders end-to-end — from choosing the right structure and incorporating, to first-year compliance, funding readiness, and ongoing ROC/GST/tax filings — so you never have to switch providers as you grow.

• One team for the whole journey — start, launch, post-launch and every annual filing after.
• Fixed, all-inclusive pricing — professional plus government fees itemised, no hidden charges.
• A dedicated CA/CS who owns your case and does not disappear after payment.
• 6,000+ founders served, 4.9/5 rating, DPIIT-recognised, 100% online.

Talk to a Legal Suvidha expert today for a free consultation and an exact, transparent quote on WhatsApp (8130645164).